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Abstract Translin and Trax are components of an RNA
binding complex initially detected in extracts of brain and testes.
Although other tissues appear to contain much lower or
negligible levels of the Translin/Trax gel-shift complex, we
found, unexpectedly, that several of these peripheral tissues
express Translin and Trax proteins at levels comparable to those
present in brain. In this study, we demonstrate that the
paradoxically low levels of the Translin/Trax complex in kidney
and other peripheral tissues are due to masking of these sites by
endogenous RNA. Thus, these findings indicate that the Translin/
Trax complex is involved in RNA processing in a broader range
of tissues than previously recognized. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Translin and Trax have been identi¢ed as protein compo-
nents of an RNA binding complex that was found to be
highly enriched in brain and testes [1^6]. Although the func-
tional role of this complex has not yet been clari¢ed, it has
been implicated in regulating cytoplasmic mRNA localization.
In spermatocytes, its association with intercellular bridges has
prompted the suggestion that it is involved in intercellular
transport of mRNAs between spermatocytes [7]. In the brain,
immunohistochemical studies have detected prominent Trans-
lin staining in neuronal dendrites [8,9], consistent with recent
studies indicating that it plays a role in localization of den-
dritic RNAs [10].
Although recent studies have focused attention on the pos-
sible role of the Translin/Trax complex in mRNA targeting, it
is important to keep in mind that Translin homomeric com-
plexes or heteromeric Translin/Trax complexes also bind with
high a⁄nity to single-stranded DNA oligonucleotides in a
sequence-speci¢c fashion [4,5,11,12]. Accordingly, Translin
and Trax have also been implicated in DNA repair or chro-
mosomal translocations [11^15]. Thus, it is possible that the
Translin/Trax complex is multi-functional and may bind to
either RNA or single-stranded DNA species in vivo.
Since gel-shift studies indicated that the Translin/Trax com-
plex is highly enriched in brain and testes compared to a wide
range of other tissues [1,2,4,5], we had assumed that Translin
and Trax proteins would display a similar, restricted pattern
of expression. However, recent studies examining the tissue
distribution of Trax mRNAs have questioned this assump-
tion, since several tissues with low or negligible levels of the
Translin/Trax gel-shift complex display Trax mRNA levels
comparable to those found in brain [16,17]. In the present
study, we have examined the tissue distributions of Translin
and Trax proteins to see if they parallel that of the Translin/
Trax gel-shift complex. Furthermore, since we detected a
marked discrepancy in some tissues between the level of the
Translin/Trax gel-shift complex and its component proteins,
we have investigated the basis for this mismatch.
2. Materials and methods
2.1. Antibody generation and immunoblot analysis
The generation of rabbit polyclonal antibodies against the C-termi-
nal peptides of either Translin or Trax has been described previously
[8]. In this study, we also used N-terminal Trax antibodies prepared in
guinea pigs and antibodies generated against full-length Translin
fused with glutathione S-transferase (GST^Translin). To generate
the guinea pig Trax antisera an N-terminal peptide of rat Trax
(KMNGKEGPGGFRKRKHDN) was conjugated to thyroglobulin.
In brief, the peptide (1 mg/ml) was incubated with thyroglobulin
(20 mg/ml) in the presence of 0.1% glutaraldehyde for 1 h at room
temperature. The coupling reaction was stopped by the addition of
glycine (200 mM) and then dialyzed against phosphate-bu¡ered saline
overnight at 4‡C. Immunoblot analysis of crude cerebellar homoge-
nates (5 Wg of protein) con¢rmed that the N-terminal Trax antiserum
detects a single protein band that migrates at the expected molecular
weight for Trax. Furthermore, preincubation of the antiserum with
the N-terminal antigen peptide (10 Wg/Wl) abolished detection of this
band.
To generate antibodies directed against the coding sequence of
Translin, a full-length rat Translin cDNA insert was subcloned into
the pGEX-2T (Pharmacia) glutathione S-transferase expression vec-
tor. Fusion protein puri¢cation, immunization, test bleeds, and pro-
duction bleeds were performed as described previously [18].
For immunoblot analysis of Translin and Trax in tissue homoge-
nates (5 Wg protein), crude antisera were used at dilutions of 1:2000
(Translin) or 1:7000 (Trax). Horseradish peroxidase-conjugated anti-
rabbit (Translin) or anti-guinea pig (Trax) antibodies were used at a
1:5000 dilution.
2.2. Gel-shift assays
Gel-shift assays were performed on crude tissue homogenates pre-
pared as follows. Fresh or frozen tissues (cerebellum, kidney, lung, or
heart) were homogenized in a solution containing 20 mM HEPES (pH
7.9), 400 mM NaCl, 20% glycerol, 1.5 mM MgCl2, 0.1 mM phenyl-
methylsulfonyl £uoride, 1 mM dithiothreitol, 1 Wg/ml leupeptin, 5 Wg/
ml aprotinin, and 20 mM NaF, incubated on ice for 15 min, and then
centrifuged at 14 000 rpm in a Microfuge for 15 min. The concentra-
tion of protein in the supernatant was determined using the BCA
protein assay (Pierce).
Gel-shift assays were performed with a single-stranded DNA oligo-
nucleotide probe, referred to as GS1, using procedures described pre-
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viously [8]. Brie£y, the GS1 oligonucleotide (5P-CTAGGAGCGG-
GGGCGCTCATG-3P) was end-labeled with [Q-32P]ATP by T4 poly-
nucleotide kinase (NEB) and puri¢ed with a Sephadex G-50 column.
5 Wg of extract protein was incubated in 12 mM HEPES (pH 7.9),
4 mM Tris^HCl (pH 7.9), 50 mM KCl, 50 mM NaCl, 1 mM EDTA,
1 mM dithiothreitol, 12% glycerol, and 2 Wg of poly(dI-dC) with
40 000 cpm of end-labeled GS1 probe in 30 Wl for 15 min at room
temperature. After this incubation, the reaction was loaded on a 4%
polyacrylamide gel. After electrophoresis to separate free and bound
probe, the gel was dried and exposed to Kodak XAR-5 ¢lm.
For ‘supershift’ experiments, 1 Wl of the GST^Translin or rabbit
Trax antisera were added 15 min after the addition of the probe. The
binding reaction was then extended for an additional 15 min. For
competition experiments, the tissue was preincubated with a 10U or
50U excess of cold GS1 oligonucleotide for 15 min before the addi-
tion of the end-labeled GS1 probe. For the RNase experiments, 10 Wg
of RNase A (Sigma) was added immediately prior to the addition of
the radiolabeled GS1 probe.
In some experiments, equal amounts (5 Wg protein) of cerebellar
and kidney extracts were combined in the gel-shift reaction. When
indicated, the kidney extract was boiled for 5 min, then cooled to
room temperature before being added to the cerebellar extracts. Pro-
teinase K (Life Technologies) (0.06 Wg) or DNase I (Sigma) (0.1 Wg)
was incubated with the indicated tissue for 5 min at 37‡C, then boiled
for 5 min to inactivate the enzymes prior to use in the gel-shift assay.
2.3. Immunoprecipitation
Kidney extracts prepared identically to those used for gel-shift as-
says were ¢rst pre-cleared by incubating them with protein A-Sephar-
ose beads (Pierce) for 1 h at 4‡C. Trax antibody (5 Wl/ml) that had
been preincubated with protein A-Sepharose beads was added to the
pre-cleared supernatant. After an additional 1 h incubation at 4‡C,
the beads were pelleted by centrifugation, washed extensively, and
processed for immunoblot analysis with Translin or Trax antibodies.
3. Results
In previous studies, we and others have reported that the
Translin/Trax gel-shift complex is highly enriched in brain and
testes with low or negligible levels of binding activity in a
variety of other tissues. Paradoxically, we found in an immu-
noblot survey of Translin and Trax protein expression that
the pattern of expression of Translin and Trax proteins does
not parallel that predicted by previous gel-shift studies. For
example, similar levels of Translin and Trax protein are de-
tected by immunoblotting in extracts of kidney, lung or cer-
ebellum (Fig. 1A), even though the ¢rst two contain much
lower levels of the Translin/Trax gel-shift complex labeled
with the GS1 probe (Fig. 1B). In contrast, heart extracts
have very low levels of both Translin and Trax proteins, as
well as the Translin/Trax gel-shift complex.
To help resolve this discrepancy between the level of ex-
pression of Translin and Trax proteins and the corresponding
gel-shift complex in several peripheral tissues, we focused our
investigation on kidney. First, we considered the possibility
that Translin and Trax do not form a complex in this tissue.
However, we found that these proteins co-precipitate from
kidney extracts, as observed previously in studies conducted
on brain extracts (Fig. 2) [8].
Next, we assessed whether kidney extracts might contain a
factor that inhibits the binding activity of the Translin/Trax
complex. To this end, we examined the e¡ect of kidney ex-
tracts on the prominent Translin/Trax gel-shift complex found
in cerebellar extracts. We found that mixing kidney and cer-
ebellar extracts produced a marked reduction in the intensity
of the cerebellar Translin/Trax gel-shift band (Fig. 3A). Im-
munoblot analysis of these gel-shift samples con¢rmed that
mixing the extracts does not cause degradation of either
Translin or Trax (data not shown), which suggests that kidney
extracts contain a factor that blocks detection of the Translin/
Trax gel-shift complex. To help determine whether this inhib-
itory factor might be a protein, we examined the e¡ect of
boiling the kidney extract prior to adding it to the cerebellar
extract. However, we found that boiling did not diminish the
inhibition (Fig. 3A). In fact, we found that boiling enhanced
the inhibitory e¡ect of kidney extracts, as boiled kidney ex-
tracts were approximately 5-fold more potent in suppressing
the cerebellar Translin/Trax gel-shift band than control kid-
ney extracts (data not shown).
Although the resistance of the inhibitory factor to boiling
argues against it being a protein, it does not rule out the
possibility that it is a heat stable protein or peptide. Accord-
ingly, we examined the e¡ect of preincubating kidney extracts
with proteinase K which was then inactivated by boiling prior
to mixing these treated kidney extracts with cerebellar ex-
tracts. However, the inhibitory factor present in kidney ex-
tracts was also una¡ected by this protease treatment. To
check that the absence of a gel-shift band was not merely
due to incomplete inactivation of the proteinase K, we con-
¢rmed that addition of the heat-treated proteinase K, in the
Fig. 1. Tissue distribution of Translin and Trax proteins and the
Translin/Trax gel-shift complex. (A) Immunoblot analysis of Trans-
lin (top panels) and Trax (bottom panels) in cerebellum (Cb), kid-
ney (K), lung (Lu) and heart (Ht) indicates that the ¢rst three tis-
sues have comparable levels of these proteins, with much lower
levels present in heart. Arrows at the left indicate the location of
either the Translin or Trax bands. (B) Gel-shift assays of the Trans-
lin/Trax complex in these tissues with the GS1 probe detect a robust
gel-shift band in cerebellar extracts with negligible binding activity
in the other three tissues. The arrow labeled GS1 indicates the loca-
tion of the Translin/Trax gel-shift complex.
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absence of kidney extracts, did not diminish the intensity of
the cerebellar gel-shift band. However, as expected, inclusion
of proteinase K that had not been heat-inactivated in the gel-
shift assay abolished the gel-shift band (Fig. 3A).
Since RNA and single-stranded DNA can bind to the
Translin/Trax gel-shift complex with high a⁄nity, we exam-
ined the possibility that endogenous RNA or single-stranded
DNA species might be bound to the complex, masking detec-
tion of the gel-shift complex. As predicted by this hypothesis,
we found that treatment of kidney extracts with RNase abol-
ished their ability to suppress detection of the gel-shift com-
plex in cerebellar extracts (Fig. 3B).
To check whether single-stranded DNA might also be in-
volved in masking detection of the complex, we performed
comparable experiments with DNase treatment of kidney ex-
tracts (Fig. 3B). However, since inclusion of DNase in the gel-
shift assay would be expected to degrade the GS1 probe, we
¢rst heat-inactivated the DNase-treated kidney extracts by
boiling prior to mixing it with the cerebellar extracts and
the probe. Following this procedure, we found that DNase
treatment did not mimic the ability of RNase to neutralize
the inhibitory activity present in kidney extracts. To con¢rm
that heat treatment did inactivate the DNase as expected, we
checked that adding heat-treated DNase directly to the gel-
shift assay of cerebellar extracts did not inhibit the intensity of
the gel-shift band. Lastly, as a positive control to check that
the DNase was able to degrade DNA, we con¢rmed that
addition of DNase to the gel-shift reaction mixture abolished
detection of the gel-shift complex by degrading the probe.
As these studies indicated that endogenous RNA present in
kidney was able to mask the Translin/Trax complex present in
cerebellum, we reasoned that a similar mechanism accounted
for our inability to detect the Translin/Trax gel-shift complex
in kidney extracts. As predicted, we found that addition of
RNase to kidney extracts revealed the presence of a robust
gel-shift complex (Fig. 4). To insure that this e¡ect of RNase
was due to its enzymatic activity, we con¢rmed that pretreat-
ment of the extracts with RNasin blocked the e¡ect of RNase.
As these ¢ndings strongly supported the view that the in-
hibitory factor present in kidney extracts is composed of
RNA, we wondered whether Translin/Trax complexes present
in brain extracts were also partially masked by binding to
endogenous RNA species. However, RNase had little e¡ect
on the intensity of the gel-shift band in cerebellum indicating
Fig. 2. Co-precipitation of Translin and Trax from kidney extracts.
The immunoprecipitate obtained from kidney extracts with Trax
antibodies was analyzed by immunoblotting with Trax (left panel)
and Translin (right panel) antibodies. Arrows to the right of each
panel indicate the expected location of either Trax (left panel) or
Translin (right panel). Neither Trax nor Translin is detected in the
immunoprecipitate when Trax antibody is omitted from the immu-
noprecipitation step. Furthermore, preincubation of the Trax anti-
body with the antigen peptide prior to the immunoprecipitation step
blocks immunoprecipitation of both proteins. As the same guinea
pig Trax antiserum was used for immunoprecipitation and immuno-
blotting, the prominent bands present in the two right lanes of the
left panel re£ect detection of the Trax IgG by the anti-guinea pig
secondary antibody. Accordingly, these bands are not present in the
Translin blot as it was processed with an anti-rabbit secondary anti-
body.
Fig. 3. Characterization of a factor present in kidney extracts that
suppresses detection of the Translin/Trax gel-shift complex in cere-
bellar extracts. (A) As shown above, cerebellar extracts (Cb) display
a robust GS1 gel-shift complex indicated by the arrow in the left
margin. Mixing of equal amounts of cerebellum and kidney extracts
(Cb+K) markedly suppresses the intensity of the gel-shift band.
Boiling of the kidney extract prior to mixing it with cerebellar ex-
tracts (Cb+B-K) enhances the suppression of the GS1 band. Treat-
ment of the kidney extract with proteinase K (PK) and then boiling
this mixture to inactivate the proteinase K prior to mixing it with
cerebellar extracts (Cb+B-(K+PK)) does not reverse the suppression.
The remaining two lanes con¢rm that boiling of the proteinase K
inactivates it, since it does not reduce the intensity of the GS1 band
present in cerebellar extracts (Cb+B-PK). As expected, in the ab-
sence of boiling, proteinase K abolishes the GS1 complex (Cb+PK).
(B) The ¢rst two lanes show the Translin/Trax gel-shift complex
present in cerebellar extracts (Cb) and the ability of boiled kidney
extract to suppress detection of this complex (Cb+B-K). The next
two lanes illustrate that treatment of the boiled kidney extract with
RNase reverses this inhibitory e¡ect (Cb+B-K+RNase), while
DNase treatment does not (Cb+B-(K+DNase)). In order to prevent
degradation of the GS1 DNA oligonucleotide probe used in this
gel-shift assay, the DNase-treated kidney extracts were boiled prior
to mixing them with the cerebellar extracts. This precaution is nec-
essary since, as expected, addition of DNase to the cerebellar ex-
tracts abolishes the GS1 gel-shift band (Cb+DNase). As shown in
the last lane to the right, we con¢rmed that the boiling treatment
used was su⁄cient to inactivate the DNase, as addition of boiled
DNase to the cerebellar extracts does not reduce the intensity of the
GS1 gel-shift band (Cb+B-DNase).
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that this is not the case (Fig. 4). Conversely, homogenization
of cerebellum in the presence of RNase inhibitor did not pro-
duce a consistent decrease in the intensity of the gel-shift band
(data not shown).
To check our assumption that the gel-shift band detected in
kidney extracts after RNase treatment corresponds to the
Translin/Trax complex, we performed ‘supershift’ studies
with antibodies to these proteins. In previous studies con-
ducted on cerebellar extracts, we found that antibodies to
Translin or Trax were able to slow the migration of the com-
plex (data not shown) [8]. We con¢rmed that the gel-shift
complex induced by RNase treatment behaved in the same
way (Fig. 5A). Furthermore, we found that the sensitivity of
the kidney complex to inhibition by unlabeled GS1 oligonu-
cleotide matched that displayed by the Translin/Trax complex
present in cerebellar extracts (Fig. 5B) [4].
As RNase treatment is able to unmask cryptic Translin/
Trax complexes in kidney extracts, we also checked whether
it has a similar e¡ect in lung, another tissue in which there is a
discrepancy between the level of the Translin/Trax gel-shift
band and its component proteins (Fig. 1). As found in kidney,
RNase treatment also increased the intensity of the Translin/
Trax gel-shift band detected in lung extracts (Fig. 6). How-
ever, as expected, RNase treatment did not unmask the pres-
ence of Translin/Trax binding complexes in heart, which has
negligible levels of both Translin and Trax proteins (Figs. 1
and 6).
4. Discussion
The goal of this study was to explain the marked discrep-
ancy in the intensity of the Translin/Trax gel-shift bands de-
tected in brain and kidney, even though these tissues contain
comparable amounts of Translin and Trax proteins. We have
found that endogenous RNA masks the complex in kidney,
preventing it from being detected by exogenous radiolabeled
probes. In contrast, Translin/Trax complexes present in cere-
bellar extracts are not masked by endogenous RNAs. Con-
ceivably, this re£ects greater susceptibility of brain RNAs to
endogenous RNase activity. Alternatively, it is possible that
kidney is enriched in RNA species that have high a⁄nity for
the Translin/Trax complex. We favor the former alternative
since we have found that RNAs isolated from cerebellum or
kidney under denaturing conditions have comparable poten-
cies in inhibiting binding of radiolabeled GS1 probe to the
Translin/Trax complex (P.M.F., unpublished observations).
In vitro studies have demonstrated that the Translin/Trax
complex can bind with high a⁄nity to either RNA or single-
stranded DNA species. Thus, it is possible that one of these
nucleic acid species, or perhaps both, are targeted by the
Translin/Trax complex in vivo. Our demonstration that the
Fig. 4. RNase treatment unmasks the GS1 gel-shift complex in kid-
ney. Treatment of kidney extracts with RNase reveals the presence
of a GS1 gel-shift complex (indicated by arrow in the left margin)
that co-migrates with that detected in cerebellar extracts. This e¡ect
of RNase is blocked by pre-treatment with RNasin. As shown in
the panel at the right, RNase does not produce a comparable e¡ect
in cerebellar extracts.
Fig. 5. Characterization of the GS1 gel-shift complex in kidney ex-
tracts. (A) Addition of antibodies to either Trax or Translin slows
the migration of the GS1 complex. Arrowheads in the right margin
indicate the location of the ‘supershifted’ gel-shift complexes. Incu-
bation with the corresponding pre-immune antisera does not pro-
duce this e¡ect (data not shown). (B) Competition studies with un-
labeled GS1 oligonucleotide demonstrate that the Translin/Trax
complex in kidney displays similar a⁄nity to that found previously
for the Translin/Trax complex in cerebellum. 10U and 50U indicate
that the concentration of unlabeled GS1 oligonucleotide was 10-fold
and 50-fold higher than that of the radiolabeled GS1 probe. Unla-
beled oligonucleotide was incubated with kidney extracts for 15 min
prior to adding the GS1 probe.
Fig. 6. E¡ect of RNase treatment on the GS1 gel-shift complex in
lung and heart. As found for kidney extracts, RNase increases the
intensity of the GS1 gel-shift band in lung (indicated by arrow).
However, RNase treatment of heart extracts does not reveal the
presence of a cryptic GS1 complex in this tissue.
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Translin/Trax complex present in several tissues is masked by
binding to endogenous RNA supports the view that the com-
plex binds to RNA in vivo. However, it is conceivable that
‘masking’ of the complex by endogenous RNA occurs during
homogenization of the tissue. Nevertheless, we favor the for-
mer alternative, since we were unable to detect binding of
radiolabeled GS1 probe to the Translin/Trax complex, even
when the GS1 probe was included in the homogenization bu¡-
er (P.M.F., unpublished observations).
Although some of the proteins implicated in dendritic RNA
processing appear to be expressed selectively in neurons, such
as Nova-1 [19,20] and the neuronal Hu proteins [21], many
others are widely expressed RNA binding proteins that have
been adapted to this purpose in neurons, such as Staufen [22^
24]. The broad tissue distribution of Translin and Trax pro-
teins indicates that these proteins fall into the latter class. To
date most studies have focused on the role of this complex in
RNA processing in brain and testes. However, our results
support the view that its role in other tissues warrants study
as well. Expanding the scope of these studies may provide
important clues to understanding the regulation and function
of this complex in RNA processing in general and also shed
light on its role in specialized situations such as dendritic
RNA processing.
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